158
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Interleukin-1β and uric acid as potential second-trimester predictive biomarkers of preeclampsia

, , &
Pages 186-192 | Received 30 Dec 2020, Accepted 20 Apr 2021, Published online: 06 May 2021

References

  • Tranquilli A, Dekker G, Magee L, et al. The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISP. Pregnancy Hypertens. 2014;4:97–104.
  • Abalos E, Ananth CV, Keyes KM, et al. Pre-eclampsia rates in the United States, 1980–2010: age-period-cohort analysis. BMJ. 2013;347:6564.
  • Osungbade KO, Ige OK. Public health perspectives of preeclampsia in developing countries: implication for health system strengthening. J Pregnancy. 2011;2011:1–6.
  • Burton GJ, Redman CW, Roberts JM, et al. Pre-eclampsia: pathophysiology and clinical implications. BMJ. 2019;366:l2381.
  • Staff AC. The two-stage placental model of preeclampsia: an update. J Reprod Immunol. 2019;134-135:1–10.
  • Redman CW, Sargent IL, Staff AC, et al. Lecture: making sense of pre-eclampsia - two placental causes of preeclampsia? Placenta. 2014;35(Suppl.):S20–5.
  • Myatt L, Webster RP. Vascular biology of preeclampsia. J Thromb Haemost. 2009;7(3):375.
  • Poon LC, Galindo A, Surbek D, et al. From first-trimester screening to risk stratification of evolving pre-eclampsia in second and third trimesters of pregnancy: a comprehensive approach. Ultrasound Obstet Gynecol. 2020;55(1):5–12. .
  • Doğan K, Guraslan H, Çankaya A, et al. Ischemia-Modified Albumin (IMA): a novel marker for preeclampsia independent of uterine artery notching identified by doppler ultrasound. Hypertens Pregnancy. 2015 Nov;34(4):516–524.
  • Taylor BD, Ness RB, Klebanoff MA, et al. First and second- trimester immune biomarkers in preeclamptic and normotensive women. Pregnancy Hypertens. 2016;6(4):388–393. .
  • Taylor BD, Tang G, Ness RB, et al. Mid-pregnancy circulating immune biomarkers in women with preeclampsia and normotensive controls. Pregnancy Hypertens. 2016;6(1):72–78. .
  • Takahashi JL, Giuliani F, Power C, et al. Interleukin −1-beta promotes oligodendrocyte death through glutamate excitotoxicity. Ann Neurol. 2003;53(5):588–595. .
  • Burtis CA, Bruns DE. Tietz fundamentals of clinical chemistry and molecular diagnostics. 7th ed. 2015.Elsevier Health Sciences: USA.
  • Nikbakht R, Moghadam EK, Nasirkhani Z. Maternal serum levels of C-reactive protein at early pregnancy to predict fetal growth restriction and preterm delivery: a prospective cohort study. Int J Reprod Biomed. 2020;18(3):157–164.
  • Lopez-Castejon G, Brough D. Understanding the mechanism of IL-1β secretion. Cytokine Growth Factor Rev. 2011 Aug;22(4):189–195.
  • Khaliq OP, Kinoshita T, Moodley J, et al. The role of uric acid in preeclampsia: is uric acid a causative factor or a sign of preeclampsia? Curr Hypertens Rep. 2018;20(9):80.
  • Braga TT, Forni MF, Correa-Costa M, et al. Soluble uric acid activates the NLRP3 inflammasome. Sci Rep. 2017;7(1):39884.
  • Kang MJ, Jo SG, Kim DJ, et al. NLRP3 inflammasome mediates interleukin-1β production in immune cells in response to Acinetobacter baumannii and contributes to pulmonary inflammation in mice. Immunology. 2017 Apr;150(4):495–505.
  • Jakobsen C, Larsen JB, Fuglsang J, et al. Platelet function in preeclampsia - a systematic review and meta-analysis. Platelets. 2019;30(5):549–562.
  • Belizán JM, Villar J, Repke J. The relationship between calcium intake and pregnancy-induced hypertension: up-to-date evidence. Am J Obstet Gynecol. 1988;158(4):898–902.
  • Hofmeyr GJ, Atallah AN, Duley L. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev. 2010;(8):CD001059. PMID: 16855957.
  • World Health Organization. Guideline: calcium supplementation in pregnant women. Geneva, Switzerland: World Health Organization; 2013.
  • Pérez-López FR, Vitamin D. The secosteroid hormone and human reproduction. Gynecol Endocrinol. 2007;23(1):13–24.
  • De-Regil LM, Palacios C, Lombardo LK, et al. Vitamin D supplementation for women during pregnancy. Cochrane Database Syst Rev. 2019 Jul ;26(7):CD008873.
  • Aghajafari F, Nagulesapillai T, Ronksley PE, et al. Association between maternal serum 25-hydroxyvitamin d level and pregnancy and neonatal outcomes: systematic review and meta-analysis of observational studies. BMJ. 2013;346:f1169.
  • Paravicini TM, Yogi A, Mazur A, et al. Dysregulation of vascular TRPM7 and annexin-1 is associated with endothelial dysfunction in inherited hypomagnesemia. Hypertension. 2009;53(2):423–429.
  • De Baaij JHF, Hoenderop JGJ, Bindels RJM. Magnesium in man: implications for health and disease. Physiol Rev. 2015;95(1):1–46.
  • Todd N, McNally R, Alqudah A, et al. Role of A novel angiogenesis FKBPL-CD44 pathway in preeclampsia risk stratification and mesenchymal stem cell treatment. J Clin Endocrinol Metab. 2021 Jan 1;106(1):26–41.
  • Zeisler H, Llurba E, Chantraine F, et al. Predictive Value of the sFlt-1: plGFRatio in women with suspected preeclampsia. N Engl J Med. 2016 Jan 7;374(1):13–22.
  • Aneman I, Pienaar D, Suvakov S, et al. Mechanisms of key innate immune cells in early- and late-onset preeclampsia. Front Immunol. 2020 Aug;18(11):1864.
  • Ma Y, Ye Y, Zhang J, et al. Immune imbalance is associated with the development of preeclampsi. Medicine (Baltimore). 2019;98:e15080.
  • Sljivancanin Jakovljevic T, Kontic-Vucinic O, Nikolic N, et al. Glutathione-S-transferase M1 polymorphism and pro-inflammatory cytokines tumor necrosis factor-α and interleukin-1β are associated with preeclampsia in Serbian women. Am J Reprod Immunol. 2019;81(5):e13105. .
  • Duan L, Liu Z, Wang L, et al. C1q and tumor necrosis factor-related protein 4 (CTRP4) suppresses caspase-1/IL-1β inflammatory pathway in trophoblasts of rat models with preeclampsia. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2016;32(11):1441–1445.
  • Zuurbier CJ, Abbate A, Cabrera-Fuentes HA, et al. Innate immunity as a target for acute cardioprotection. Cardiovasc Res. 2019 Jun 1;115(7):1131–1142.
  • Mansoura S, Makedou K, Theodoridis T, et al. The involvement of uric acid in the pathogenesis of preeclampsia. Curr Hypertens Rev. 2015;11(2):110–115.
  • Bellos I, Pergialiotis V, Loutradis D, et al. The prognostic role of serum uric acid levels in preeclampsia: a meta-analysis. J Clin Hypertens (Greenwich). 2020 May;22(5):826–834.
  • Doğan K, Guraslan H, Senturk MB, et al. Can platelet count and platelet indices predict the risk and the prognosis of preeclampsia? Hypertens Pregnancy. 2015 Nov;34(4):434–442.
  • Özdemirci Ş, Başer E, Kasapoğlu T, et al. Predictivity of mean platelet volume in severe preeclamptic women. Hypertens Pregnancy. 2016 Nov;35(4):474–482.
  • Udenze I, Amadi C, Awolola N, et al. The role of cytokines as inflammatory mediators in preeclampsia. Pan Afr Med J. 2015;20:219.
  • Cebesoy FB, Balat O, Dikensoy E, et al. CA-125 and CRP are elevated in preeclampsia. Hypertens Pregnancy. 2009;28(2):201–211. .
  • Given MA, Coskun A, Ertas IE, et al. Association of maternal serum CRP, IL-6, TNF-alpha, homocysteine, folic acid, and vitamin B12 levels with the severity of preeclampsia and fetal birth weight. Hypertens Pregnancy. 2009;28(2):190–200. .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.